The Conference Forum Announces the launch of DPharm, the First Event on
Disruptive Innovations in Clinical Trials
*Strange, I don't see GERN or ACTC there...must be just for the Animal Pharms..
NEW YORK, May 31, 2011 (BUSINESS WIRE) -- The Conference Forum announced the
launch of DPharm, Disruptive Innovations in Clinical Trials, the first event of
its kind on transformative and disruptive approaches to advancing clinical
trials. Led by Pfizer and Novartis, this conference is designed in a similar
style to the TED events with a highly informative and engaging format.
"This conference is a unique opportunity for a community of leaders in our
industry to explore, challenge and co-create bleeding-edge approaches in clinical
research," said Advisory Board member, Puneet Sapra, Director, World Wide
Business Development & Innovation at Pfizer.
Several vital areas in clinical development will be addressed by disruptive
thinkers who can impart their strategies on:
1. Challenges and Opportunities in Clinical Development 2. Innovations in Science
Applied to Clinical Development 3. Innovations in Technology Applied to Clinical
Development 4. New Business Models for Clinical Development
The speaking faculty includes:
Margaret A. Anderson Executive Director FasterCures/The Center for Accelerating
Medical Solutions
Marc Cantillon, MD Executive Director, Coalition Against Major Diseases (CAMD)
Critical Path Institute (C-Path)
Sohini Chowdhury Vice President, Research Partnerships The Michael J. Fox
Foundation for Parkinson's Research
Kathleen Goin Associate Director, Clinical Trial Manager Endo Pharmaceuticals
Magali Haas, MD, PhD Partner Janssen R&D Innovation at Johnson & Johnson
Benjamin Heywood Co-Founder, President and Director PatientsLikeMe
Steve E. Labkoff, MD, FACP Specialist Leader, Health Information Technology
AstraZeneca
Craig H. Lipset Head of Clinical Innovation, Development Operations Pfizer, Inc.
Jules T. Mitchel, MBA, PhD President Target Health Inc.
John Orloff, MD Senior Vice President, Global Development & Chief Medical Officer
Novartis Pharma AG
Scott D. Patterson, PhD Executive Director, Medical Sciences Amgen Inc.
Jon Platt, MA Oxon Leader, Healthcare Sector ?WHATIF! Innovation
Peter J. Pitts President and Co-Founder Center for Medicine in the Public
Interest
Noah Rosenberg MD Executive Medical Director, Head of Cardiovascular/Metabolism,
Clinical Development Forest Research Institute
Tomasz Sablinski, PhD, MD Managing Director Celtic Therapeutics
Puneet Sapra, MBA Director, World Wide Business Development & Innovation Pfizer,
Inc.
Diane Shoda Director, Worldwide Regulatory Strategy, Board Member NEWDIGS Pfizer
Inc.
Greg Simon Senior Vice President Worldwide Policy Pfizer
Bruce W. Turnbull, PhD, PStat Professor of Statistics Cornell University
The DPharm conference takes place September 15-16, 2011 at the Loews Hotel in
Philadelphia, PA. For more information on the program case studies, please visit
theconferenceforum.org or call 646 350 2580.
SOURCE: The Conference Forum
The Conference Forum
Valerie Bowling, 646-350-2585
Vbowling@theconferenceforum.org |
